Uterine fibroids are common non-cancerous tumors that can affect fertility. Submucosal fibroids that distort the uterine cavity have been shown to decrease pregnancy rates, while evidence for intramural fibroids is less clear. Treatment options include medical therapy, uterine artery embolization, hysteroscopic or laparoscopic myomectomy. Myomectomy can improve fertility outcomes, especially for submucosal fibroids, but carries risks of adhesion formation and possible increased risk of uterine rupture in future pregnancies. More research is still needed to fully understand the relationship between fibroid location, size and infertility.
This document discusses types of fibroids and their impact on fertility. It describes 3 main types of fibroids - submucosal, intramural, and subserosal - and provides details on their classification systems. The document also summarizes several mechanisms by which fibroids can affect fertility, including effects on fertilization and implantation. It reviews findings on the relationship between fibroid characteristics like location, size, and number and fertility outcomes like pregnancy rates. The document concludes by outlining treatment options for fibroids impacting fertility, including expectant management, medical therapies, and various surgical approaches.
Invited Lecture delivered by Dr Sujoy Dasgupta in a CME, sponsored by Serum Institute of India Pvt Ltd in the Convocation Ceremony of Interns at Sagor Dutta Medical College
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assementAtef Darwish
This document discusses recommendations for assessing polycystic ovary syndrome (PCOS). It covers diagnostic criteria including irregular menstrual cycles, hyperandrogenism, polycystic ovarian morphology on ultrasound, and anti-Müllerian hormone levels. It also discusses assessing cardiovascular, metabolic, and reproductive health risks associated with PCOS, including insulin resistance, impaired glucose tolerance, diabetes, and obesity. Ethnic variations in PCOS presentation and long-term health risks are also addressed.
This document provides an overview of intrauterine insemination (IUI). Some key points include:
IUI is a first-line, non-invasive fertility treatment that involves placing processed sperm directly into the uterus. Success rates range from 6-20% depending on the stimulation protocol used. Factors like age, infertility duration and etiology, and semen quality impact success rates. Strict monitoring is important to minimize risks of ovarian hyperstimulation syndrome while maximizing pregnancy chances. Proper sperm processing techniques and timing of insemination relative to ovulation are also important considerations for IUI.
Uterine fibroids are common non-cancerous tumors that can affect fertility. Submucosal fibroids that distort the uterine cavity have been shown to decrease pregnancy rates, while evidence for intramural fibroids is less clear. Treatment options include medical therapy, uterine artery embolization, hysteroscopic or laparoscopic myomectomy. Myomectomy can improve fertility outcomes, especially for submucosal fibroids, but carries risks of adhesion formation and possible increased risk of uterine rupture in future pregnancies. More research is still needed to fully understand the relationship between fibroid location, size and infertility.
This document discusses types of fibroids and their impact on fertility. It describes 3 main types of fibroids - submucosal, intramural, and subserosal - and provides details on their classification systems. The document also summarizes several mechanisms by which fibroids can affect fertility, including effects on fertilization and implantation. It reviews findings on the relationship between fibroid characteristics like location, size, and number and fertility outcomes like pregnancy rates. The document concludes by outlining treatment options for fibroids impacting fertility, including expectant management, medical therapies, and various surgical approaches.
Invited Lecture delivered by Dr Sujoy Dasgupta in a CME, sponsored by Serum Institute of India Pvt Ltd in the Convocation Ceremony of Interns at Sagor Dutta Medical College
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assementAtef Darwish
This document discusses recommendations for assessing polycystic ovary syndrome (PCOS). It covers diagnostic criteria including irregular menstrual cycles, hyperandrogenism, polycystic ovarian morphology on ultrasound, and anti-Müllerian hormone levels. It also discusses assessing cardiovascular, metabolic, and reproductive health risks associated with PCOS, including insulin resistance, impaired glucose tolerance, diabetes, and obesity. Ethnic variations in PCOS presentation and long-term health risks are also addressed.
This document provides an overview of intrauterine insemination (IUI). Some key points include:
IUI is a first-line, non-invasive fertility treatment that involves placing processed sperm directly into the uterus. Success rates range from 6-20% depending on the stimulation protocol used. Factors like age, infertility duration and etiology, and semen quality impact success rates. Strict monitoring is important to minimize risks of ovarian hyperstimulation syndrome while maximizing pregnancy chances. Proper sperm processing techniques and timing of insemination relative to ovulation are also important considerations for IUI.
PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)Lifecare Centre
PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)
MODERATOR
DR SHARDA JAIN
DR JYOTI AGARWAL
DR ILA GUPTA
UMA RAI
RAJ BOKARIA
JYOTI AGARWAL
JYOTI BHASKER
RENU CHAWLA
DIPTI NABH
VANDANA GUPTA
Hysterectomy vs levonorgestrel inter-uterine device
Hysterectomy was the most cost-effective treatment
Progesterone receptor modulators for the treatment of uterine fibroids
Progesterone receptor modulators (ulipristal acetate or mifepristone) were also identified as a potential new treatment by members of the Guideline Development group (GDG)
Pre-surgical medical treatment of uterine fibroids (progesterone receptor modulaters and gonadotrophin releasing hormone analogues)
The new evidence may favour ulipristal acetate over gonadotrophin releasing hormone analogue for some, but not all outcomes as a pre-treatment for uterine fibroids before myomectomy
The document is a lecture on the treatment of endometriosis-associated infertility according to 2022 ESHRE guidelines. It discusses various treatment options including medical treatment with hormonal therapies, surgery, assisted reproductive technologies (ART), and fertility preservation. Key recommendations include that ovarian suppression should not be used to improve fertility. Surgery and ART may be considered depending on the stage of endometriosis and patient factors. Extensive counseling is recommended when discussing fertility preservation options.
IUI remains an effective treatment option for certain fertility issues like unexplained infertility, mild male factor infertility, and infertility due to cervical factors. Stimulated IUI cycles have higher success rates than natural cycles. Optimal timing of IUI is 36-40 hours after hCG administration. IUI can be considered for poor responders to IVF as an alternative to cancellation. Success rates of IUI decline significantly after age 40. IUI may not be as effective as IVF for cases involving distal unilateral tubal blockage or hydrosalpinx. Strict protocols should be followed when performing IUI for HIV discordant couples.
This document contains information from Dr. Shashwat Jani regarding ovarian stimulation protocols for IUI. It discusses various stimulation options including clomiphene citrate, letrozole, gonadotropins, and combinations. It provides details on dosing, monitoring, and the advantages and disadvantages of different protocols. The goal of stimulation is to develop multiple follicles to improve pregnancy rates with IUI or develop a single follicle for anovulatory patients.
- There is consensus that submucosal fibroids interfere with fertility and should be removed in infertile patients, regardless of size or symptoms. Subserosal fibroids do not impact fertility.
- The impact of intramural fibroids on fertility is still uncertain. Some studies show they may reduce clinical pregnancy and increase miscarriage rates, while other studies show no effect.
- The benefits of myomectomy for interstitial or intramural fibroids are unclear, as evidence is limited and conflicting. Myomectomy may be considered for failed IVF cycles or large fibroids distorting the cavity.
- There are ongoing controversies around the impact of fibroid number, location and size,
Since the first formal description of LPD in 1949 as a possible cause of infertility and recurrent miscarriage by Jones. Innumerable investigations have been undertaken in an effort to verify its existence or to characterize its pathophysiology, diagnosis, and treatment. The consensus of the literature is that LPD does exist and that its cause is multifactorial like abnormal folliculogenesis, inadequate LH surge,inadequate secretion of progesterone by the corpus luteum, aberrant end-organ response by the endometrium.
Ultrasound plays a key role in evaluating infertility by assessing ovarian reserve, endometrial thickness and blood flow, detecting uterine anomalies, guiding oocyte retrieval and embryo transfer. New markers of endometrial receptivity and follicle development aim to improve success with single embryo transfer. Three-dimensional ultrasound enhances detection of uterine anomalies and may improve embryo visualization during transfer.
PROTOCOLSIntra Uterine Insemination (sharing personal experience) Lifecare Centre
This document provides information on intrauterine insemination (IUI), including prerequisites, indications, steps, and factors affecting success rates. It summarizes that IUI is a relatively simple and inexpensive fertility treatment that involves placing sperm directly into the uterus. Success rates are affected by factors like total motile sperm count, with counts over 5 million critical. Density gradient preparation is superior to swim-up for abnormal semen. DNA fragmentation levels also impact rates. Guidelines on when to consider IVF instead of further IUI cycles include age over 37, more than 4 failed cycles, severe male factors, and certain ovarian response patterns.
This document discusses recurrent pregnancy loss and provides information on definitions, incidence, causes, investigations, and guidelines. Some key points:
- Recurrent pregnancy loss is defined as 3 or more clinically recognized pregnancy losses before 20 weeks. The incidence is about 1 in 300 pregnancies.
- Common causes include genetic factors in the parents or embryo, anatomic abnormalities, endocrine/immune/infectious factors, and inherited thrombophilias.
- Investigations should include parental karyotyping after 2 losses, and karyotyping of pregnancy tissues is recommended by RCOG guidelines to provide counseling and predict outcomes of future pregnancies.
- Biomarkers and ultrasound can provide information on predicting outcomes,
This document discusses the management of endometriosis associated infertility. It begins with the incidence and diagnosis of endometriosis and endometriomas. It then discusses treatment options including IVF, surgery, and aspiration. IVF is recommended as the first line treatment, as the presence of an endometrioma does not negatively impact IVF outcomes. Surgery is not recommended prior to IVF unless needed for pain or inability to access follicles. Aspiration is not recommended before IVF except in cases where an endometrioma may hinder oocyte retrieval. The conclusion cites French guidelines that found no impact of endometriomas on IVF results, and recommends against pre-IVF surgery or asp
Indivisualization of Ovulation Induction - Dr Dhorepatil BharatiBharati Dhorepatil
IVF started to develop fast with the aim of maximizing pregnancy rates per cycle
Higher number of oocytes and thus more embryos
Use of unphysiological high doses of gonadotropins
Time consuming protocols
Higher costs
Patient discomfort
Higher risk of OHSS
Very high risk of multiple gestation
This document discusses endometriosis and its relationship to infertility. It covers several key points:
1. Endometriosis has three main types - peritoneal, ovarian, and rectovaginal - which are different entities.
2. Endometriosis can result in infertility through mechanical effects, endocrine abnormalities, changes to peritoneal fluid, immune system issues, and defects in oocytes.
3. Diagnosis is confirmed through laparoscopy, and mild or minimal endometriosis associated with infertility can be treated through laparoscopic destruction, expectant management, or GnRH agonists. Surgery aims to decrease inflammation and toxicity.
4. For endometriomas,
This document provides biographical information about Dr. Narendra Malhotra, an obstetrician and gynecologist from India. It lists his professional roles and accomplishments, which include being president of FOGSI, dean of ICMU, director of the Ian Donald School of Ultrasound, and editor of several medical books and journals. It also provides contact information for Malhotra Hospitals in Agra, India, where Dr. Malhotra practices and serves as a consultant for IVF procedures in several other cities.
Intrapartum sonography can be used to more accurately assess fetal head position, station, descent, and rotation during labor compared to digital examination alone. It also helps predict success of induction of labor and instrumental delivery. The document outlines the basic technique, objectives, and various clinical applications of intrapartum sonography during different stages of labor.
This document provides an overview of basic infertility investigations. It defines primary and secondary infertility and discusses the most common causes of infertility including female factors like ovulation disorders, tubal abnormalities, and uterine issues as well as male factors. It outlines the initial tests that should be performed on both partners to investigate infertility including testing for ovulation, evaluating male factor issues, and assessing tubal patency. Physical exams, histories, and occasionally laparoscopy/hysteroscopy are important initial steps in the evaluation process. The goal of initial investigations is to identify treatable causes of infertility for the couple.
all the informations taken from Sperrof 8th edition
all the informations are upto date
especially designed for MD MS student in Obstetrics and gynaecology doing their Residency
Uterine fibroids and endometrial polyps are common lesions in the female genital tract, and often they are asymptomatic. However, if the lesions are occupying and distorting the uterine cavity, they may cause symptoms such as abnormal uterine bleeding, subfertility and pregnancy losses. This review will discuss the impact of uterine cavity fibroids and polyps on subfertility and pregnancy losses and whether the removal of these lesions will improve reproductive outcome.
Fibroid occur commonly in female of reproductive age. They are a common variant in Sub-fertility practice. "To treat" or "To Not treat" is a clinical dilemma in vast majority of cases. Here, i describe the pertinent literature so that you can make a informed decision on management of fibroids.
PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)Lifecare Centre
PANEL DISCUSSION ON ENDOMETRIOSIS RELATED INFERTILITY (EVIDENCE BASED)
MODERATOR
DR SHARDA JAIN
DR JYOTI AGARWAL
DR ILA GUPTA
UMA RAI
RAJ BOKARIA
JYOTI AGARWAL
JYOTI BHASKER
RENU CHAWLA
DIPTI NABH
VANDANA GUPTA
Hysterectomy vs levonorgestrel inter-uterine device
Hysterectomy was the most cost-effective treatment
Progesterone receptor modulators for the treatment of uterine fibroids
Progesterone receptor modulators (ulipristal acetate or mifepristone) were also identified as a potential new treatment by members of the Guideline Development group (GDG)
Pre-surgical medical treatment of uterine fibroids (progesterone receptor modulaters and gonadotrophin releasing hormone analogues)
The new evidence may favour ulipristal acetate over gonadotrophin releasing hormone analogue for some, but not all outcomes as a pre-treatment for uterine fibroids before myomectomy
The document is a lecture on the treatment of endometriosis-associated infertility according to 2022 ESHRE guidelines. It discusses various treatment options including medical treatment with hormonal therapies, surgery, assisted reproductive technologies (ART), and fertility preservation. Key recommendations include that ovarian suppression should not be used to improve fertility. Surgery and ART may be considered depending on the stage of endometriosis and patient factors. Extensive counseling is recommended when discussing fertility preservation options.
IUI remains an effective treatment option for certain fertility issues like unexplained infertility, mild male factor infertility, and infertility due to cervical factors. Stimulated IUI cycles have higher success rates than natural cycles. Optimal timing of IUI is 36-40 hours after hCG administration. IUI can be considered for poor responders to IVF as an alternative to cancellation. Success rates of IUI decline significantly after age 40. IUI may not be as effective as IVF for cases involving distal unilateral tubal blockage or hydrosalpinx. Strict protocols should be followed when performing IUI for HIV discordant couples.
This document contains information from Dr. Shashwat Jani regarding ovarian stimulation protocols for IUI. It discusses various stimulation options including clomiphene citrate, letrozole, gonadotropins, and combinations. It provides details on dosing, monitoring, and the advantages and disadvantages of different protocols. The goal of stimulation is to develop multiple follicles to improve pregnancy rates with IUI or develop a single follicle for anovulatory patients.
- There is consensus that submucosal fibroids interfere with fertility and should be removed in infertile patients, regardless of size or symptoms. Subserosal fibroids do not impact fertility.
- The impact of intramural fibroids on fertility is still uncertain. Some studies show they may reduce clinical pregnancy and increase miscarriage rates, while other studies show no effect.
- The benefits of myomectomy for interstitial or intramural fibroids are unclear, as evidence is limited and conflicting. Myomectomy may be considered for failed IVF cycles or large fibroids distorting the cavity.
- There are ongoing controversies around the impact of fibroid number, location and size,
Since the first formal description of LPD in 1949 as a possible cause of infertility and recurrent miscarriage by Jones. Innumerable investigations have been undertaken in an effort to verify its existence or to characterize its pathophysiology, diagnosis, and treatment. The consensus of the literature is that LPD does exist and that its cause is multifactorial like abnormal folliculogenesis, inadequate LH surge,inadequate secretion of progesterone by the corpus luteum, aberrant end-organ response by the endometrium.
Ultrasound plays a key role in evaluating infertility by assessing ovarian reserve, endometrial thickness and blood flow, detecting uterine anomalies, guiding oocyte retrieval and embryo transfer. New markers of endometrial receptivity and follicle development aim to improve success with single embryo transfer. Three-dimensional ultrasound enhances detection of uterine anomalies and may improve embryo visualization during transfer.
PROTOCOLSIntra Uterine Insemination (sharing personal experience) Lifecare Centre
This document provides information on intrauterine insemination (IUI), including prerequisites, indications, steps, and factors affecting success rates. It summarizes that IUI is a relatively simple and inexpensive fertility treatment that involves placing sperm directly into the uterus. Success rates are affected by factors like total motile sperm count, with counts over 5 million critical. Density gradient preparation is superior to swim-up for abnormal semen. DNA fragmentation levels also impact rates. Guidelines on when to consider IVF instead of further IUI cycles include age over 37, more than 4 failed cycles, severe male factors, and certain ovarian response patterns.
This document discusses recurrent pregnancy loss and provides information on definitions, incidence, causes, investigations, and guidelines. Some key points:
- Recurrent pregnancy loss is defined as 3 or more clinically recognized pregnancy losses before 20 weeks. The incidence is about 1 in 300 pregnancies.
- Common causes include genetic factors in the parents or embryo, anatomic abnormalities, endocrine/immune/infectious factors, and inherited thrombophilias.
- Investigations should include parental karyotyping after 2 losses, and karyotyping of pregnancy tissues is recommended by RCOG guidelines to provide counseling and predict outcomes of future pregnancies.
- Biomarkers and ultrasound can provide information on predicting outcomes,
This document discusses the management of endometriosis associated infertility. It begins with the incidence and diagnosis of endometriosis and endometriomas. It then discusses treatment options including IVF, surgery, and aspiration. IVF is recommended as the first line treatment, as the presence of an endometrioma does not negatively impact IVF outcomes. Surgery is not recommended prior to IVF unless needed for pain or inability to access follicles. Aspiration is not recommended before IVF except in cases where an endometrioma may hinder oocyte retrieval. The conclusion cites French guidelines that found no impact of endometriomas on IVF results, and recommends against pre-IVF surgery or asp
Indivisualization of Ovulation Induction - Dr Dhorepatil BharatiBharati Dhorepatil
IVF started to develop fast with the aim of maximizing pregnancy rates per cycle
Higher number of oocytes and thus more embryos
Use of unphysiological high doses of gonadotropins
Time consuming protocols
Higher costs
Patient discomfort
Higher risk of OHSS
Very high risk of multiple gestation
This document discusses endometriosis and its relationship to infertility. It covers several key points:
1. Endometriosis has three main types - peritoneal, ovarian, and rectovaginal - which are different entities.
2. Endometriosis can result in infertility through mechanical effects, endocrine abnormalities, changes to peritoneal fluid, immune system issues, and defects in oocytes.
3. Diagnosis is confirmed through laparoscopy, and mild or minimal endometriosis associated with infertility can be treated through laparoscopic destruction, expectant management, or GnRH agonists. Surgery aims to decrease inflammation and toxicity.
4. For endometriomas,
This document provides biographical information about Dr. Narendra Malhotra, an obstetrician and gynecologist from India. It lists his professional roles and accomplishments, which include being president of FOGSI, dean of ICMU, director of the Ian Donald School of Ultrasound, and editor of several medical books and journals. It also provides contact information for Malhotra Hospitals in Agra, India, where Dr. Malhotra practices and serves as a consultant for IVF procedures in several other cities.
Intrapartum sonography can be used to more accurately assess fetal head position, station, descent, and rotation during labor compared to digital examination alone. It also helps predict success of induction of labor and instrumental delivery. The document outlines the basic technique, objectives, and various clinical applications of intrapartum sonography during different stages of labor.
This document provides an overview of basic infertility investigations. It defines primary and secondary infertility and discusses the most common causes of infertility including female factors like ovulation disorders, tubal abnormalities, and uterine issues as well as male factors. It outlines the initial tests that should be performed on both partners to investigate infertility including testing for ovulation, evaluating male factor issues, and assessing tubal patency. Physical exams, histories, and occasionally laparoscopy/hysteroscopy are important initial steps in the evaluation process. The goal of initial investigations is to identify treatable causes of infertility for the couple.
all the informations taken from Sperrof 8th edition
all the informations are upto date
especially designed for MD MS student in Obstetrics and gynaecology doing their Residency
Uterine fibroids and endometrial polyps are common lesions in the female genital tract, and often they are asymptomatic. However, if the lesions are occupying and distorting the uterine cavity, they may cause symptoms such as abnormal uterine bleeding, subfertility and pregnancy losses. This review will discuss the impact of uterine cavity fibroids and polyps on subfertility and pregnancy losses and whether the removal of these lesions will improve reproductive outcome.
Fibroid occur commonly in female of reproductive age. They are a common variant in Sub-fertility practice. "To treat" or "To Not treat" is a clinical dilemma in vast majority of cases. Here, i describe the pertinent literature so that you can make a informed decision on management of fibroids.
1. Endometriosis can negatively impact ovarian reserve by damaging follicles through inflammation, fibrosis, and reduced vascularization caused by the disease itself or surgery to remove endometriotic cysts.
2. Anti-Mullerian hormone (AMH) levels tend to be lower in women with endometriosis, with more severe reductions seen with bilateral disease, larger cysts, more fibrosis, and longer disease duration.
3. When considering surgery or fertility treatments for endometriosis patients with low ovarian reserve, factors like the woman's age, infertility duration, pelvic pain levels, recurrence risk, and ovarian reserve markers must be evaluated individually to optimize outcomes while preserving future fertility potential.
The Management of Uterine Fibroids in Women With Otherwise Unexplained Infer...Aboubakr Elnashar
This document provides guidelines for the management of uterine fibroids in women with otherwise unexplained infertility. It finds that submucosal fibroids should be removed to improve conception rates, while removal of subserosal fibroids is not recommended. For intramural fibroids, evidence suggests myomectomy may not improve fertility outcomes. Hysteroscopic removal is appropriate for small submucosal fibroids. The guidelines also find that uterine artery embolization is not recommended due to lower pregnancy rates and more complications compared to myomectomy.
A Retrospective Study on Evaluation of Patients with Uterine Fibroid in a Ter...ijtsrd
Uterine fibroids are a major cause of morbidity in women of reproductive age. Hence it is important to evaluate the occurrence of fibroid. An observational retrospective study was carried out in Obstetric and Gynecology Department over a period of 2 months. Each of the cases was scrutinized for sociodemographic, clinical profile and other necessary information. In this study, Fibroid was found to be predominant in premenopausal women. .Parity and number of abortions had no much significance with fibroid diagnosed. The primary management of obese patients were found as weight reduction and diet control. Hysterectomy was done based on large fibroid size. Anju Mam Thomas | Blessy Rachal Boban | Jiya Ann Mathew "A Retrospective Study on Evaluation of Patients with Uterine Fibroid in a Tertiary Care Hospital" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-2 , February 2019, URL: https://www.ijtsrd.com/papers/ijtsrd20311.pdf
Paper URL: https://www.ijtsrd.com/pharmacy/pharmacy-practice/20311/a-retrospective-study-on-evaluation-of-patients-with-uterine-fibroid-in-a-tertiary-care-hospital/anju-mam-thomas
Uterine fibroids are common non-cancerous tumors that can affect fertility. While their exact effects are still being established, submucosal fibroids which distort the uterine cavity have been shown to decrease pregnancy rates. Myomectomy surgery to remove fibroids, especially those that are submucosal, can improve fertility outcomes by halving miscarriage risks and increasing pregnancy rates to similar levels as women without fibroids. The optimal treatment depends on factors like fibroid location, size and number, as well as the patient's fertility desires.
Uterine fibroids are common non-cancerous tumors that can affect fertility. While their exact effects are still being established, submucosal fibroids which distort the uterine cavity have been shown to decrease pregnancy rates. Myomectomy surgery to remove fibroids, especially those that are submucosal, can improve fertility outcomes by halving miscarriage risks and increasing pregnancy rates to similar levels as women without fibroids. The optimal treatment depends on factors like fibroid location, size and number, as well as the patient's age and fertility desires.
This document discusses the management of uterine fibroids. It defines fibroids as benign tumors of the myometrium. Symptoms vary and include menstrual problems, pressure symptoms, and reproductive dysfunction like infertility. Diagnosis involves imaging like ultrasound and MRI. Treatment options include expectant management for asymptomatic cases, medical treatment to relieve symptoms using drugs like progesterone or GnRH analogues, and surgical options like hysterectomy or myomectomy. Factors in surgical decision making include size and location of fibroids, desire for future fertility, and expertise of the surgeon. Myomectomy aims to preserve the uterus but carries risks of recurrence and complications in future pregnancies.
This document discusses endometriosis and its impact on fertility and IVF outcomes. It provides information on diagnosing and treating endometriosis, including:
- Laparoscopy is the gold standard for diagnosing endometriosis. Surgical excision of endometriomas and deep endometriosis can improve pain and fertility outcomes.
- For subfertility, treatment depends on factors like disease severity, pain levels, and reproductive plans. IVF is an option if conservative treatments fail.
- Studies show endometriosis may reduce ovarian response and increase IVF cancellation rates. However, it does not significantly impact live birth, pregnancy, or miscarriage rates compared to other infertility factors
Fertility Preservation For Cancer PatientsMamdouh Sabry
Fertility preservation is possible if suitable techniques are started early, before chemotherapy or radiotherapy for cancer patients. For men, sperm cryopreservation is effective but hormonal suppression is not recommended. For women, embryo cryopreservation is established while oocyte cryopreservation is becoming a good option. Ovarian tissue cryopreservation and transplantation is experimental. Pregnancy after breast cancer treatment does not imply a worse prognosis. Chemotherapy during pregnancy can be introduced for hematologic malignancies. Fertility preservation should be considered for cancer patients before gonadotoxic treatment and for others diseases requiring such treatment.
This document discusses the physiology and pathology of placental delivery. It begins by explaining the importance of understanding placental delivery due to risks of postpartum hemorrhage. It then covers the normal physiology of placental delivery in 3 phases. It discusses the role of the myometrium and mediators like nitric oxide. Pathologies like retained placenta and placenta accreta are defined. Risk factors, prophylaxis, and management of retained placenta are summarized. The role of ultrasound, medications, techniques like the Pipingas method are mentioned for treatment.
Uterine Fibroids (Leiomyomata): Investigations and Treatment Michelle Fynes
Uterine fibroids (UF) are the most common benign neoplastic threat to women's health, costing hundreds of billions of health care dollars worldwide. The objective of this presentation is to review risk factors, aetiology, classification and clinical presentation of Uterine fibroids.
1. Endometrial scratch therapy is a simple procedure done to improve embryo implantation and pregnancy rates in women undergoing ART. It involves gently scratching the endometrial lining using a catheter.
2. The proposed mechanisms by which it works include improving endometrial receptivity through regeneration of the endometrium and increased production of growth factors and cytokines.
3. Several studies have found endometrial scratching increases clinical pregnancy and live birth rates, especially in women with recurrent implantation failure undergoing IVF or IUI. It is a low-cost procedure with minimal risk.
This document discusses the management of infertility in women with endometriosis. It covers topics such as the relationship between endometriosis and infertility, guidelines for treatment, the pathophysiology of endometriosis-related infertility, diagnosing endometriosis, medical and surgical treatment options, assisted reproduction techniques for endometriosis patients, and specific considerations for deep endometriosis, endometriomas, and unexplained infertility. Treatment aims to relieve symptoms, remove or destroy endometrial lesions, and potentially improve fertility outcomes through methods like laparoscopic surgery, hormonal therapies, IUI, and IVF. However, the evidence on most effective approaches is still limited.
Recent trends in the mnagement of fibrioddrmcbansal
This document discusses recent advances in fibroid management. It summarizes that fibroids are benign tumors arising from the uterus that can be single or multiple. Recent research shows specific genetic mutations are associated with fibroids. Treatment options discussed include medical management using drugs like NSAIDs, IUDs, and danazol, as well as surgical options like myomectomy, hysterectomy, and newer minimally invasive procedures like uterine artery embolization and radiofrequency ablation.
Management Of Endometriosis Related Infertility By Dr. Abayomi Ajayiabayomi ajayi
1) Endometriosis affects 10% of women and can cause infertility in 30-50% of cases. It involves the growth of endometrial tissue outside the uterus and comes in three main types.
2) The exact ways endometriosis causes infertility are unclear but likely involve anatomical distortion, tubal occlusion, reduced oocyte quality, and impaired endometrial receptivity.
3) Treatment options for endometriosis-related infertility include surgery, assisted reproductive technologies (ART) like IUI or IVF, and medical therapies like danazol or GnRH agonists, though medicines alone do not improve pregnancy rates. A comprehensive fertility assessment is needed to determine the best individual approach.
Dr. Sunita Chandra, Chairperson & Director-Rajendra Nagar Hospital & IVF Centre and Mopheus Lucknow Fertility Centre gave the talk on IVF PREGNANCY at webinar on March 27,2021
This document discusses abnormal uterine bleeding (AUB), including definitions, prevalence, assessment, causes, and management. Some key points:
- AUB is irregular bleeding that affects 10-30% of reproductive-aged women. It has many potential causes and can seriously impact quality of life.
- Assessment involves history, physical exam, blood tests, imaging like ultrasound and potentially biopsy. The Pictorial Blood Assessment Chart scores bleeding to indicate if it is heavy.
- Causes vary by age but include issues like fibroids, polyps, hormonal imbalances, and cancer. The 2018 FIGO classification system standardized terminology.
- Initial treatment is usually medical like hormones, NSAIDs, or tran
This document provides information about Premature Ovarian Insufficiency (POI) from Dr. Sunita Chandra. It defines POI, discusses its incidence and mechanisms. It covers the aetiology, clinical presentation, diagnosis, and long-term management of POI through hormone treatment. Hormone treatment aims to mimic natural hormone levels and is generally continued until the average age of natural menopause to prevent long-term health issues. Treatment approaches may differ for those with POI before or after puberty.
Dr. Sunita Chandra discusses evaluating and treating infertile couples. Approximately 15-20 million couples in India suffer from infertility. A standard evaluation includes medical history, physical exam, and tests of both partners. For females, tests include day 2-3 FSH, AMH, ultrasound to check ovaries and tubes, and HSG to check tube patency. For males, semen analysis is most important to check volume, count, motility, and morphology. Counseling is also important throughout evaluation and treatment. The most common causes of infertility are problems with ovulation, tubal factors, uterine issues, and age.
This document summarizes information on preterm birth (PTB) and the use of progesterone supplementation to prevent PTB. It begins by defining PTB as birth before 37 weeks gestation. It then discusses risk factors for PTB like previous preterm births, infections, cervical factors. It describes evaluating cervical length via transvaginal ultrasound to predict risk. Progesterone supplementation options are discussed including various formulations and 17-alpha hydroxyprogesterone caproate injections. The document summarizes evidence that progesterone reduces rates of preterm birth and improves neonatal outcomes.
Luteal phase support in assisted reproductive technology (ART)Dr. Sunita Chandra
This document provides information on luteal phase support in assisted reproductive technology (ART). It discusses that the luteal phase is characterized by progesterone secretion from the corpus luteum, which is important for endometrial receptivity and early pregnancy development. However, in stimulated ART cycles, high estrogen levels can cause luteal phase insufficiency. Various options for luteal phase support are discussed, including human chorionic gonadotropin, progestogens administered vaginally, intramuscularly or orally, and gonadotropin-releasing hormone agonists. The benefits and limitations of different agents are summarized.
Dr. Sunita Chandra is the Chairperson and Director of Rajendra Nagar Hospital & IVF Centre and Director of Morpheus Lucknow Fertility Centre. She has extensive training and experience in fertility and IVF in India and Germany. She has published research papers and book chapters on fertility-related topics. She has held several leadership roles in fertility-related organizations and has spoken at numerous national and international conferences. She has received several awards for her contributions to medicine and healthcare in Uttar Pradesh.
Dr. Sunita Chandra discusses improving results in IUI (intrauterine insemination). IUI involves sperm processing and placement into the uterine cavity with a catheter. IUI can be effective for infertility due to ovulation disorders, unexplained infertility, and mild male factor infertility. The success of IUI depends on factors like age, ovarian reserve, patient selection, ovulation induction, cycle monitoring and timing, and luteal phase support. Dr. Chandra provides guidance on patient workup, stimulation protocols, trigger timing, and IUI timing to optimize IUI outcomes.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
4. 20-40% OF WOMEN OF REPRODUCTIVE AGE
ASSOCIATED WITH INFERTILITY : 5-10%
ONLY CAUSE OF INFERTILITY: 2-3%
5. Fibroids (myomas or
leiomyomas) are non-
cancerous tumors which grow
in or around the uterus,
developing from cells that
make up the uterus.
This is a very common
condition, affecting between
30-77% of women during their
reproductive years.
6.
7.
8. •Exact cause is unknown.
•Fibroid growth is affected by the reproductive hormones estrogen and
progesterone.
•Genetic predisposition
•Myometrial and leiomyoma stem cell have been identified that transform and
grow into fibroids under the influence of hormones
•Fibroids have higher concentrations of estradiol, aromatase,progesterone
receptor ER α
•However it is progesterone that influences the proliferation of fibroids
12. Most fibroids do not affect a woman’s fertility.
They are mostly found as incidental findings
during an ultrasound scan and the vast majority
have no effect and do not need any treatment.
The critical aspect is whether the fibroid is
distorting the lining of the uterus, which most
do not.
13. • Where the fibroid is very large distorting the
lining of the uterus
• Where the fibroid is located inside the uterus
itself (called a sub mucous fibroid).
In these two situations, surgery to remove the fibroid may be
needed.
However, most fibroids do not need any treatment at all.
14. Effect on fertilization Effect on implantation
Anatomic distortion of the
cervix
Altered endometrial development
Altered uterine contractility Prevention of efflux of discharge or
blood
Deformity of the endometrial
cavity
Distortion of the shape of the
endometrium
Obstruction of tubal ostia
MECHANISMS BY WHICH FIBROIDS
AFFECT REPRODUCTIVE FUNCTION
SUBMUCOSAL FIBROIDES ALSO LEADS TO LOWER PREGNANCY
IMPLANTATION AND DELIVERY RATES
(Cook H et al 2010)
15.
16. 1. Physical Factors:
• Given their size and location, it is unsurprising that simple
physical impedance to the transport of sperm, egg or
embryo has been proffered as a mechanism to explain the
anti-fertility effects of fibroids.
2. Alteration of Uterine Contractions:
• Uterine contractions increase in frequency in the early
follicular phase from the fundus to cervix whereas in peri-
ovulatory and luteal phase, their direction is reversed from
the cervix to fundus.
• Fibroids are also known to influence the contractility of
the myometrium and induce a chronic inflammatory
reaction, both of which may hinder implantation
17. 3.Cytokine Factors:
•Certain early pregnancy intrauterine cytokines are thought to
be responsible for implantation and early embryonic
development.
•Ben-Nagi et al. reported significant reduction in levels of
certain cytokines mainly IL10 and glycodelin in the mid-luteal
uterine washings of women with submucosal fibroids
•Glycodelin is a progesterone-regulated glycoprotein secreted
into uterine luminal cavity by secretory/decidualized
endometrial glands and has properties like promoting
angiogenesis and suppressing natural killer (NK) cells.
18. 4.Genetic:
•Endometrial HOXA10, HOXA11 and BTEB1 gene
expression has been shown to modulate
endometrial receptivity.
•The reduction or absence of HOXA10 in the
uterine endometrium leads to infertility due to
the inability of the embryo to implant.
•The downregulation of endometrial HOXA 1 gene
expression results in defective decidualization
possibly mediated via secretion of transforming
growth factor beta3 (TGF-β3).
19. Alterations in the Endo-myometrial Junctional
(EMJ) Zone:
•The EMJ which represents the inner 1/3rd of the
myometrium abutting the endometrium contributes
macrophages and uterine natural killer (uNK) cells
which are essential for the process of endometrial
decidualization in the mid-luteal window of
implantation.
• In women with uterine fibroids, Kitaya et al. found
significant reduction in concentrations of both
macrophages and uNK cells in the EMJ, thus,
negatively affecting implantation.
21. Treatment depends on
Type & severity of symptoms
Size of myomas
Location of myoma,
Patient age
Reproductive plans , obstetrics history
22. 1. Infertile patients without any identifiable
etiology except uterine myomas
2. Asymptomatic fibroid
3. About 3- 7% of fibroides can regress over
6 months to 3 years in premenopausal
women
Expectant Management
23. Oral contraceptives
GnRH agonist eg: Leuprolide, triptorelin
GnRH antagonist
Progestins
LNG IUD – Levonorgestral IntraUterine Device
SPRMs-Selective progestreone receptor
modulator
Ulipristal Acetate (UPA) ( Croxtall JD et al 2012)
Vilaprisan ( stronger than UPA, but phase III
trials underway ( Bradley L et al 2016)
24. Mifepristone
Raloxifene
Aromatse inhibitors
Anti- Fibrinolitic agents
FUTURE TREATMENTS
EGCG- Green tea extract ( appears to block each stage of tumor
genesis, clinic trials are needed)
Lanreotide (long acting somatostatin analogue)
28. Depending on the myoma size, presence of anemia and the surgeon's
skill, hysteroscopic myomectomy combined or not with ulipristal
acetate(UPA) should be proposed
31. systematic review is designed to include these new
studies along with the previously reviewed
manuscripts to address two questions:
1) Do uterine fibroids, of specific size or location,
decrease fertility?; and
2) does removal of the fibroid(s) enhance fertility?
Of 347 studies initially evaluated, 23 were included
in the data analysis
Fertil Steril 2009;91:1215–23.
32. Fertility outcomes are decreased in women with
submucosal fibroids, and removal seems to
confer benefit.
Subserosal fibroids do not affect fertility
outcomes, and removal does not confer benefit.
Intramural fibroids appear to decrease fertility
Fertil Steril 2009;91:1215–23.
33. -Pregnancy after myomectomy 75% in
1st y
PR drops sharply after this time
(Dessole et al, 2001).
If possible, therefore, myomectomy
should be timed when a woman is ready
to start a family
10-75% (mean:
50%)(Donnez & jadoul, 2000).
The differences may be attributed to:
1.Age & other infertility factors
2.Factors related to fibroid
3.Technical factors
34. The approach depend on:
Fibroid: Site, number and size
Surgeon: Expertise
Patient: preference
35.
36. 1.In women with infertility, an effort should be made to
adequately evaluate and classify fibroids, particularly
those impinging on the endometrial cavity, using
transvaginal ultrasound, hysteroscopy,
hysterosonography, or magnetic resonance imaging.
(IIIA)
2.Preoperative assessment of submucosal fibroids
should include, in addition to an assessment of fibroid
size and location within the uterine cavity, evaluation of
the degree of invasion of the cavity and thickness of
residual myometrium to the serosa. A combination of
hysteroscopy and transvaginal ultrasound or
hysterosonography are the modalities of choice. (IIIB)
37. 3.Submucosal fibroids are managed
hysteroscopically. The fibroid size should be <
5 cm, although larger fibroids have been
managed hysteroscopically, but repeat
procedures are often necessary. (IIIB)
4.A hysterosalpingogram is not an appropriate
exam to evaluate and classify fibroids. (IIID)
5.In women with otherwise unexplained
infertility, submucosal fibroids should be
removed in order to improve conception and
pregnancy rates.
(II2A)
38. 6.Removal of subserosal fibroids is not
recommended. (IIID)
7.There is fair evidence to recommend against
myomectomy in women with intramural fibroids
(hysteroscopically confirmed intact
endometrium) and otherwise unexplained
infertility, regardless of their size. (II2D)
If the patient has no other options, the benefits
of myomectomy should be weighed against the
risks, and management of intramural fibroids
should be individualized. (IIIC)
39. 8.If fibroids are removed abdominally, efforts should be
made to use an anterior uterine incision to minimize the
formation of postoperative adhesions. (II2A)
9.Widespread use of the laparoscopic approach to
myomectomy may be limited by the technical difficulty of
this procedure. Patient selection should be
individualized based on the number, size, and location
of uterine fibroids and the skill of the surgeon. (IIIA)
10.Women, fertile or infertile, seeking future pregnancy
should not generally be offered uterine artery
embolization as a treatment option for uterine fibroids.
(II3E).
40. Q 1 WHAT TYPE OF FIBROIDS AFFECT FERTILITY
• LEOMYOMAS THAT DISTORT THE UTERINE CAVITIES
•( submucosal or intramural)
•Q 2 WHAT IS THE IMPACT OF SMALL CAVITY DISTORTING INTRAMURAL
FIBROIDS ON ART
•CONTROVERTIAL
•SINGNIFICAT REDUCTION IN CLINICAL AND ONGOING PREGNANCY RATES
WITH INTRAMURAL FIBROIDS OF ≤ 5 cm
41. Q 3 IS MYOMECTAMY RECOMMENDED BEFORE IVF IN NON DISTORTING
FIBROIDS?
THE PATIENTS SHOULD BE COUNCELLED THAT THEY HAVE SIMILAR
OUTCOMES WITH THOSE TAHT HAVE NO FIBROIDS
Q 4 WHAT COMPLECATION OCCUR IN PREGNANCY WITH FIBROIDS ?
PAIN FUL DEGENARATION
MISCARRIAGE
PREMATURE DELIVERY
ABNORMAL FOETAL POSITION
PLACENTAL ABSUPTION
Figure 7 Management of type 0 myomas. Hysteroscopic myomectomy is the most appropriate approach. Fibroid classification cartoon republished with permission from Munro et al. (2011).
Figure 8 Management of type 1 myomas. Depending on the myoma size, presence of anemia and the surgeon&apos;s skill, hysteroscopic myomectomy combined or not with ulipristal acetate(UPA) should be proposed. Fibroid classification cartoon republished with permission from Munro et al.(2011).
Figure 12 Management of type 2 to 5 myomas or multiple myomas (type 2–5) in premenopausal women wishing to preserve their uterus. In this case, long-term (four courses of three months) intermittent therapy with SPRMs is proposed. Fibroid classification cartoon republished with permission from Munro et al. (2011).